136 related articles for article (PubMed ID: 9484853)
1. Glutamate release in human cerebral cortex and its modulation by 5-hydroxytryptamine acting at h 5-HT1D receptors.
Maura G; Marcoli M; Tortarolo M; Andrioli GC; Raiteri M
Br J Pharmacol; 1998 Jan; 123(1):45-50. PubMed ID: 9484853
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological diversity between native human 5-HT1B and 5-HT1D receptors sited on different neurons and involved in different functions.
Marcoli M; Maura G; Munari C; Ruelle A; Raiteri M
Br J Pharmacol; 1999 Feb; 126(3):607-12. PubMed ID: 10188970
[TBL] [Abstract][Full Text] [Related]
3. Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex.
Bühlen M; Fink K; Böing C; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):281-9. PubMed ID: 8692282
[TBL] [Abstract][Full Text] [Related]
4. Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors.
Schlicker E; Fink K; Molderings GJ; Price GW; Duckworth M; Gaster L; Middlemiss DN; Zentner J; Likungu J; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):321-7. PubMed ID: 9303568
[TBL] [Abstract][Full Text] [Related]
5. Release-regulating serotonin 5-HT1D autoreceptors in human cerebral cortex.
Maura G; Thellung S; Andrioli GC; Ruelle A; Raiteri M
J Neurochem; 1993 Mar; 60(3):1179-82. PubMed ID: 8382263
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of noradrenaline release via presynaptic 5-HT1D alpha receptors in human atrium.
Molderings GJ; Frölich D; Likungu J; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):272-80. PubMed ID: 8692281
[TBL] [Abstract][Full Text] [Related]
7. 5-HT1B receptors modulate release of [3H]dopamine from rat striatal synaptosomes: further evidence using 5-HT moduline, polyclonal 5-HT1B receptor antibodies and 5-HT1B receptor knock-out mice.
Sarhan H; Grimaldi B; Hen R; Fillion G
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):12-8. PubMed ID: 10651141
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques.
Nilsson T; Longmore J; Shaw D; Pantev E; Bard JA; Branchek T; Edvinsson L
Eur J Pharmacol; 1999 May; 372(1):49-56. PubMed ID: 10374714
[TBL] [Abstract][Full Text] [Related]
9. 5-HT1D receptors regulate 5-HT release in the rat raphe nuclei. In vivo voltammetry and in vitro superfusion studies.
Piñeyro G; de Montigny C; Blier P
Neuropsychopharmacology; 1995 Nov; 13(3):249-60. PubMed ID: 8602897
[TBL] [Abstract][Full Text] [Related]
10. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
11. Participation of 5-HT1-like and 5-HT2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs.
Verheggen R; Freudenthaler S; Meyer-Dulheuer F; Kaumann AJ
Br J Pharmacol; 1996 Jan; 117(2):283-92. PubMed ID: 8789380
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological profile of the receptors that mediate external carotid vasoconstriction by 5-HT in vagosympathectomized dogs.
Villalón CM; Ramírez-San Juan E; Castillo C; Castillo E; López-Muñoz FJ; Terrón JA
Br J Pharmacol; 1995 Nov; 116(6):2778-84. PubMed ID: 8591004
[TBL] [Abstract][Full Text] [Related]
13. Promotion of cell growth by stimulation of cloned human 5-HT1D receptor sites in transfected C6-glial cells is highly sensitive to intrinsic activity at 5-HT1D receptors.
Pauwels PJ; Wurch T; Palmier C; Colpaert FC
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):136-44. PubMed ID: 8857590
[TBL] [Abstract][Full Text] [Related]
14. Differential sensitivity of 5-HT1B auto and heteroreceptors.
Sarhan H; Fillion G
Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):382-90. PubMed ID: 10551275
[TBL] [Abstract][Full Text] [Related]
15. 5-HT1B receptor-mediated contractions in human temporal artery: evidence from selective antagonists and 5-HT receptor mRNA expression.
Verheggen R; Hundeshagen AG; Brown AM; Schindler M; Kaumann AJ
Br J Pharmacol; 1998 Aug; 124(7):1345-54. PubMed ID: 9723944
[TBL] [Abstract][Full Text] [Related]
16. Evidence for 5-HT1-like receptor-mediated vasoconstriction in human pulmonary artery.
MacLean MR; Clayton RA; Templeton AG; Morecroft I
Br J Pharmacol; 1996 Sep; 119(2):277-82. PubMed ID: 8886409
[TBL] [Abstract][Full Text] [Related]
17. Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors.
Kaumann AJ; Frenken M; Posival H; Brown AM
Circulation; 1994 Sep; 90(3):1141-53. PubMed ID: 8087924
[TBL] [Abstract][Full Text] [Related]
18. Serotonin 5-HT1D and 5-HT1A receptors respectively mediate inhibition of glutamate release and inhibition of cyclic GMP production in rat cerebellum in vitro.
Maura G; Raiteri M
J Neurochem; 1996 Jan; 66(1):203-9. PubMed ID: 8522955
[TBL] [Abstract][Full Text] [Related]
19. How efficacious are 5-HT1B/D receptor ligands: an answer from GTP gamma S binding studies with stably transfected C6-glial cell lines.
Pauwels PJ; Tardif S; Palmier C; Wurch T; Colpaert FC
Neuropharmacology; 1997; 36(4-5):499-512. PubMed ID: 9225275
[TBL] [Abstract][Full Text] [Related]
20. Release of endogenous aspartate from rat cerebellum slices and synaptosomes: inhibition mediated by a 5-HT2 receptor and by a 5-HT1 receptor of a possibly novel subtype.
Maura G; Barzizza A; Folghera S; Raiteri M
Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar; 343(3):229-36. PubMed ID: 1830929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
